This study was approved by the Institutional Review Board of the University Health Network, Toronto. We describe 12 patients who were assessed clinically, radiologically, and pathologically (n=1) at the University Health Network between 2004 and 2014. Brain imaging was performed using a 3T (n=5) or 1.5T (n=7) magnetic resonance imaging (MRI) scanner. Blood-sensitive MRI pulse sequences included 3-dimensional susceptibility-weighted imaging with phase mapping (n=11) or 2-dimensional T2*-weighted gradient echo imaging (n=1) with computed tomography to enable differentiation between hemosiderin and calcification. Additional pulse sequences included a minimum of diffusion-, T1-, T2-weighted, and T2-weighted fluid attenuation inversion recovery MRI.
C erebral microbleeds (petechial hemorrhages) are a wellknown consequence of chronic hypertension, cerebral amyloid angiopathy, and diffuse axonal injury among other causes. In each of these disorders, microbleeds involve particular regions of the brain; for example, basal ganglia and thalamic microbleeds predominate in hypertension, 1 whereas parietal-occipital cortical microbleeds predominate in cerebral amyloid angiopathy. 2 We report the clinical and radiological findings of a unique and extensive cerebral microbleed phenomenon in patients with critical illness.
Stroke
April 2017 pulmonary arteriovenous malformation, or hematuria. Five patients died during their admission. Five of the 7 survivors had cognitive deficits (such as concentration difficulty and shortterm memory impairment) documented in the clinical records, but no formal neurocognitive assessment was obtained.
Neuroimaging
Brain MRI in all 12 patients showed extensive microbleeds, diffusely involving the juxtacortical white matter and corpus callosum but sparing the cortex, deep and periventricular white matter, basal ganglia, and thalami ( Figure [D] ). Several patients also had diffuse involvement of the internal capsules, brain stem, or middle cerebellar peduncles (Table I in the online-only Data Supplement). Microbleeds were visible only on the blood-sensitive MRI sequences in 11 out of 12 patients. Four patients had follow-up brain MRI; median interval was 1 year (range, 1-36 months), and there was no change in the appearance of the microbleeds.
Laboratory
There was a laboratory-confirmed bacterial or viral infection in the lungs or blood in 9 out of 12 patients, but no particular organism predominated. No patient had H1N1 influenza, previously reported 3 in association with cerebral microbleeds. Eleven patients had thrombocytopenia (platelets ≤100×10 9 /L), and 8 out of 12 patients had severe thrombocytopenia (≤50×10 9 /L). Eleven patients had prolonged prothrombin time, and 9 had prolonged activated partial thromboplastin time.
Neuropathology
One patient (patient 10) died 2 months after the brain MRI and had an autopsy. The gross appearance of the brain was unremarkable. Histopathologic evaluation of the corpus callosum demonstrated small clusters of free red blood cells and red blood cells within macrophages, consistent with recent microbleeds ( Figure I in the online-only Data Supplement), and surrounding degradation of myelinated fibers.
Discussion
We have described a cerebral microbleed phenomenon in patients with critical illness. These microbleeds diffusely involve the juxtacortical white matter and corpus callosum and spare the deep and periventricular white matter and the gray matter.
A combination of clinical and radiological ( Figure II in the online-only Data Supplement) findings suggests that this entity is distinct from the well-known microbleed phenomena. The patients are decades younger than is typical for sporadic cerebral amyloid angiopathy, and the extensive corpus callosum involvement is also atypical for amyloid angiopathy. Only 2 patients had chronic hypertension, and no patients had the deep gray matter involvement typical of hypertensive microbleeds. Two patients had sickle cell disease, and it has been suggested that cerebral microbleeds are a consequence of fat emboli in this context; however, fat emboli typically also cause punctate foci of restricted diffusion in the brain, 4 which was absent in both patients. No patient had head trauma to explain the microbleeds as a manifestation of diffuse axonal injury. No patient had brain radiation to explain them as radiation-induced capillary telangiectasias.
Corpus callosum-predominant microbleeds have been described in patients with high-altitude exposure, 5, 6 and a recent report noted the resemblance of such microbleeds with the corpus callosum microbleeds in 3 patients with acute respiratory distress syndrome. 7 Reviewing the published images, we see that the patients with high-altitude exposure and those with acute respiratory distress syndrome also had microbleeds in the juxtacortical white matter. The similarity between high-altitude exposure microbleeds and critical illness-associated microbleeds suggests that they may have a common pathogenesis. Hypoxemia is a common factor, and hypoxia-induced hydrostatic or chemical effects on the blood-brain barrier could potentially account for extravasation of erythrocytes. 7, 8 The 12 patients in our series did not have a history of high-altitude exposure, but all 12 had respiratory failure with periods of hypoxemia.
Another possible explanation for critical illness-associated cerebral microbleeds is disseminated intravascular coagulation (DIC). Accurate diagnosis of DIC is challenging. We had sufficient data to calculate a formal DIC score for 5 patients in our series, and this categorized 4 of these patients as having overt DIC. 9 Several additional patients had clinical conditions (such as sepsis) or laboratory findings (such as severe thrombocytopenia) that are associated with DIC, suggesting that there may have been additional instances of DIC.
Recent case reports 3,10-13 have described patients with microbleeds resembling those in our series. Microbleeds in one patient 10 were attributed to hemorrhagic infectious encephalitis, but we note that this patient was also hypoxemic and admitted to an ICU. Microbleeds in 2 other patients 11 were attributed to tacrolimus and posterior reversible encephalopathy syndrome, but microbleeds in posterior reversible encephalopathy syndrome typically have parietal-occipital predominance rather than the diffuse juxtacortical and corpus callosum distribution apparent in these cases. These 2 patients both had double lung transplants, raising the possibility that hypoxemia or other factors related to ICU admission were contributory. Microbleeds in another case 13 were attributed to disseminated intravascular coagulation, and this patient was also intubated. Microbleeds in 6 other patients 3, 12 were attributed specifically to extracorporeal membrane oxygenation, but given that 9 patients in our series had respiratory failure without extracorporeal membrane oxygenation, it is difficult to know whether extracorporeal membrane oxygenation or the underlying respiratory failure was responsible in these 6 cases.
Conclusions
We have described a cerebral microbleed phenomenon with clinical and radiological features, which are distinct from the well-known microbleed phenomena. Given that critical illness is a common factor in all of our cases, and potentially all of the related published case reports, it is possible that the mechanism underlying this unique microbleed phenomenon relates to an aspect of critical illness rather than a specific underlying disease. Respiratory failure was the most common factor, present in nearly every case, but this descriptive study cannot prove causation. The clinical impact of these critical illnessassociated microbleeds is uncertain, but in other contexts, research has shown that cerebral microbleeds are independently associated with cognitive impairment and disability. 14 Unexplained, persistent cognitive impairment is common after an ICU admission, and further investigation of these critical illness-associated microbleeds is likely warranted.
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